-
CELLULIS TECHNOLOGY LIMBO™ HAS BEEN GRANTED A US PATENT
Cellulis S.L., a leader in novel cryopreservation technologies, has been granted US Patent No. 14/487,686 to its innovative cryopreservation platform Limbo™.
Friday, May 5, 2017 - 14:23
- Cellulis has been awarded “Seal of Excellence” by the European Commission Cellulis has been awarded the prestigious “Seal of Excellence” issued by the European Commission for Friday, November 25, 2016 - 14:01
- Cellulis & El Referente Wednesday, November 19, 2014 - 10:15
- Cellulis Presentation at South Summit 2014 Wednesday, November 5, 2014 - 12:44
- An Interview with Cellulis´ CSO Friday, October 31, 2014 - 13:36
- Cellulis one of twelve companies selected 12 proyectos relacionados con Wednesday, October 1, 2014 - 16:46
- Cellulis finalist in The South Summit 2014 Wednesday, October 1, 2014 - 16:39
- Democratization of cell therapy Monday, September 29, 2014 - 11:42
- Cellulis finalist company in "The South Summit" contest! Our company has been chosen among the first 100 high-tech companies out of over 3000 competitors for Monday, September 29, 2014 - 11:23
- Meet Cellulis at BioSpain 2014 Cellulis attended BioSpain 2014 Monday, September 29, 2014 - 11:05
- Meet us in San Diego 2014 Monday, June 2, 2014 - 17:30
- New Company Name On April 2014, ZF BIOTOX changed its name to CELLULIS. Wednesday, April 16, 2014 - 17:04
- ZF BIOTOX and SBH Sciences Join forces to offer Cell in Well™ service to the US Biotech Industry ZF BIOTOX has partnered with SBH Sciences Inc. Tuesday, June 11, 2013 - 12:39
-
ZF Biotox at BioChicago 2013!
ZF Biotox at Biochicago 2013!!
Sunday, January 13, 2013 - 09:38 - ZF BIOTOX at The Anglonordic Biotech Conference ZF BIOTOX will be attending The Anglonordic Biotech Conference in London next 24th May 2012. Friday, January 11, 2013 - 23:33
- ZF Biotox at BioBoston! ZF Biotox at BioBoston International Convention 2012 from 18th to 21th of June 2012 Friday, January 11, 2013 - 18:59